Genzyme (GENZ) announced that it has agreed to sell Genzyme Genetics to Laboratory Corporation of America Holdings (LabCorp) (LH) for for $925 million in cash.
Cambridge, Mass.-based Genzyme said that under the terms of the agreement, LabCorp will purchase the genetic testing business in its entirety, and is committed to offer employment to the unit’s approximately 1,900 employees upon closing,…
Continue reading Genzyme Sells Genetic Testing Unit to LabCorp for $925 Million
Genzyme Sells Genetic Testing Unit to LabCorp for $925 Million originally appeared on DailyFinance on Mon, 13 Sep 2010 06:59:00.
Filed Under: Investing, Genzyme Corporation , Sanofi Aventis, Stocks in the News